img

Radiopharmaceuticals


Published on: 2024-01-04 | No of Pages : 133 | Industry : Pharma & Healthcare

Publisher : H | Format : PDF&Excel

Radiopharmaceuticals

The global Radiopharmaceuticals market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on H newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

Bracco Imaging

GE Healthcare

Nordion

Bayer

IBA Group

Mallinckrodt

Jubilant Pharma

Lantheus

Triad Isotopes

China Isotope & Radiation

Navidea

Eli Lilly

Dongcheng

Advanced Accelerator Applications

SIEMENS



By Types

Diagnostic Radioisotopes

Therapeutic Radioisotopes



By Applications

Oncology

Cardiology

Other



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Radiopharmaceuticals Revenue

1.5 Market Analysis by Type

1.5.1 Global Radiopharmaceuticals Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Diagnostic Radioisotopes

1.5.3 Therapeutic Radioisotopes

1.6 Market by Application

1.6.1 Global Radiopharmaceuticals Market Share by Application: 2022-2027

1.6.2 Oncology

1.6.3 Cardiology

1.6.4 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Radiopharmaceuticals Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Radiopharmaceuticals Market Players Profiles

3.1 Bracco Imaging

3.1.1 Bracco Imaging Company Profile

3.1.2 Bracco Imaging Radiopharmaceuticals Product Specification

3.1.3 Bracco Imaging Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 GE Healthcare

3.2.1 GE Healthcare Company Profile

3.2.2 GE Healthcare Radiopharmaceuticals Product Specification

3.2.3 GE Healthcare Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Nordion

3.3.1 Nordion Company Profile

3.3.2 Nordion Radiopharmaceuticals Product Specification

3.3.3 Nordion Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Bayer

3.4.1 Bayer Company Profile

3.4.2 Bayer Radiopharmaceuticals Product Specification

3.4.3 Bayer Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 IBA Group

3.5.1 IBA Group Company Profile

3.5.2 IBA Group Radiopharmaceuticals Product Specification

3.5.3 IBA Group Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Mallinckrodt

3.6.1 Mallinckrodt Company Profile

3.6.2 Mallinckrodt Radiopharmaceuticals Product Specification

3.6.3 Mallinckrodt Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Jubilant Pharma

3.7.1 Jubilant Pharma Company Profile

3.7.2 Jubilant Pharma Radiopharmaceuticals Product Specification

3.7.3 Jubilant Pharma Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Lantheus

3.8.1 Lantheus Company Profile

3.8.2 Lantheus Radiopharmaceuticals Product Specification

3.8.3 Lantheus Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Triad Isotopes

3.9.1 Triad Isotopes Company Profile

3.9.2 Triad Isotopes Radiopharmaceuticals Product Specification

3.9.3 Triad Isotopes Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 China Isotope & Radiation

3.10.1 China Isotope & Radiation Company Profile

3.10.2 China Isotope & Radiation Radiopharmaceuticals Product Specification

3.10.3 China Isotope & Radiation Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Navidea

3.11.1 Navidea Company Profile

3.11.2 Navidea Radiopharmaceuticals Product Specification

3.11.3 Navidea Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Eli Lilly

3.12.1 Eli Lilly Company Profile

3.12.2 Eli Lilly Radiopharmaceuticals Product Specification

3.12.3 Eli Lilly Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Dongcheng

3.13.1 Dongcheng Company Profile

3.13.2 Dongcheng Radiopharmaceuticals Product Specification

3.13.3 Dongcheng Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Advanced Accelerator Applications

3.14.1 Advanced Accelerator Applications Company Profile

3.14.2 Advanced Accelerator Applications Radiopharmaceuticals Product Specification

3.14.3 Advanced Accelerator Applications Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 SIEMENS

3.15.1 SIEMENS Company Profile

3.15.2 SIEMENS Radiopharmaceuticals Product Specification

3.15.3 SIEMENS Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Radiopharmaceuticals Market Competition by Market Players

4.1 Global Radiopharmaceuticals Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Radiopharmaceuticals Revenue Market Share by Market Players (2016-2021)

4.3 Global Radiopharmaceuticals Average Price by Market Players (2016-2021)

5 Global Radiopharmaceuticals Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Radiopharmaceuticals Market Size (2016-2021)

5.1.2 Radiopharmaceuticals Key Players in North America (2016-2021)

5.1.3 North America Radiopharmaceuticals Market Size by Type (2016-2021)

5.1.4 North America Radiopharmaceuticals Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Radiopharmaceuticals Market Size (2016-2021)

5.2.2 Radiopharmaceuticals Key Players in East Asia (2016-2021)

5.2.3 East Asia Radiopharmaceuticals Market Size by Type (2016-2021)

5.2.4 East Asia Radiopharmaceuticals Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Radiopharmaceuticals Market Size (2016-2021)

5.3.2 Radiopharmaceuticals Key Players in Europe (2016-2021)

5.3.3 Europe Radiopharmaceuticals Market Size by Type (2016-2021)

5.3.4 Europe Radiopharmaceuticals Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Radiopharmaceuticals Market Size (2016-2021)

5.4.2 Radiopharmaceuticals Key Players in South Asia (2016-2021)

5.4.3 South Asia Radiopharmaceuticals Market Size by Type (2016-2021)

5.4.4 South Asia Radiopharmaceuticals Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Radiopharmaceuticals Market Size (2016-2021)

5.5.2 Radiopharmaceuticals Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Radiopharmaceuticals Market Size by Type (2016-2021)

5.5.4 Southeast Asia Radiopharmaceuticals Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Radiopharmaceuticals Market Size (2016-2021)

5.6.2 Radiopharmaceuticals Key Players in Middle East (2016-2021)

5.6.3 Middle East Radiopharmaceuticals Market Size by Type (2016-2021)

5.6.4 Middle East Radiopharmaceuticals Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Radiopharmaceuticals Market Size (2016-2021)

5.7.2 Radiopharmaceuticals Key Players in Africa (2016-2021)

5.7.3 Africa Radiopharmaceuticals Market Size by Type (2016-2021)

5.7.4 Africa Radiopharmaceuticals Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Radiopharmaceuticals Market Size (2016-2021)

5.8.2 Radiopharmaceuticals Key Players in Oceania (2016-2021)

5.8.3 Oceania Radiopharmaceuticals Market Size by Type (2016-2021)

5.8.4 Oceania Radiopharmaceuticals Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Radiopharmaceuticals Market Size (2016-2021)

5.9.2 Radiopharmaceuticals Key Players in South America (2016-2021)

5.9.3 South America Radiopharmaceuticals Market Size by Type (2016-2021)

5.9.4 South America Radiopharmaceuticals Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Radiopharmaceuticals Market Size (2016-2021)

5.10.2 Radiopharmaceuticals Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Radiopharmaceuticals Market Size by Type (2016-2021)

5.10.4 Rest of the World Radiopharmaceuticals Market Size by Application (2016-2021)

6 Global Radiopharmaceuticals Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Radiopharmaceuticals Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Radiopharmaceuticals Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Radiopharmaceuticals Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Radiopharmaceuticals Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Radiopharmaceuticals Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Radiopharmaceuticals Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Radiopharmaceuticals Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Radiopharmaceuticals Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Radiopharmaceuticals Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Radiopharmaceuticals Consumption by Countries

7 Global Radiopharmaceuticals Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Radiopharmaceuticals (2022-2027)

7.2 Global Forecasted Revenue of Radiopharmaceuticals (2022-2027)

7.3 Global Forecasted Price of Radiopharmaceuticals (2022-2027)

7.4 Global Forecasted Production of Radiopharmaceuticals by Region (2022-2027)

7.4.1 North America Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.3 Europe Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.7 Africa Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.9 South America Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Radiopharmaceuticals by Application (2022-2027)

8 Global Radiopharmaceuticals Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Radiopharmaceuticals by Country

8.2 East Asia Market Forecasted Consumption of Radiopharmaceuticals by Country

8.3 Europe Market Forecasted Consumption of Radiopharmaceuticals by Countriy

8.4 South Asia Forecasted Consumption of Radiopharmaceuticals by Country

8.5 Southeast Asia Forecasted Consumption of Radiopharmaceuticals by Country

8.6 Middle East Forecasted Consumption of Radiopharmaceuticals by Country

8.7 Africa Forecasted Consumption of Radiopharmaceuticals by Country

8.8 Oceania Forecasted Consumption of Radiopharmaceuticals by Country

8.9 South America Forecasted Consumption of Radiopharmaceuticals by Country

8.10 Rest of the world Forecasted Consumption of Radiopharmaceuticals by Country

9 Global Radiopharmaceuticals Sales by Type (2016-2027)

9.1 Global Radiopharmaceuticals Historic Market Size by Type (2016-2021)

9.2 Global Radiopharmaceuticals Forecasted Market Size by Type (2022-2027)

10 Global Radiopharmaceuticals Consumption by Application (2016-2027)

10.1 Global Radiopharmaceuticals Historic Market Size by Application (2016-2021)

10.2 Global Radiopharmaceuticals Forecasted Market Size by Application (2022-2027)

11 Global Radiopharmaceuticals Manufacturing Cost Analysis

11.1 Radiopharmaceuticals Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Radiopharmaceuticals

12 Global Radiopharmaceuticals Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Radiopharmaceuticals Distributors List

12.3 Radiopharmaceuticals Customers

12.4 Radiopharmaceuticals Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Radiopharmaceuticals Revenue (US$ Million) 2016-2021

Table 6. Global Radiopharmaceuticals Market Size by Type (US$ Million): 2022-2027

Table 7. Diagnostic Radioisotopes Features

Table 8. Therapeutic Radioisotopes Features

Table 16. Global Radiopharmaceuticals Market Size by Application (US$ Million): 2022-2027

Table 17. Oncology Case Studies

Table 18. Cardiology Case Studies

Table 19. Other Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Radiopharmaceuticals Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Radiopharmaceuticals Market Growth Strategy

Table 46. Radiopharmaceuticals SWOT Analysis

Table 47. Bracco Imaging Radiopharmaceuticals Product Specification

Table 48. Bracco Imaging Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. GE Healthcare Radiopharmaceuticals Product Specification

Table 50. GE Healthcare Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Nordion Radiopharmaceuticals Product Specification

Table 52. Nordion Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Bayer Radiopharmaceuticals Product Specification

Table 54. Table Bayer Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. IBA Group Radiopharmaceuticals Product Specification

Table 56. IBA Group Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Mallinckrodt Radiopharmaceuticals Product Specification

Table 58. Mallinckrodt Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Jubilant Pharma Radiopharmaceuticals Product Specification

Table 60. Jubilant Pharma Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Lantheus Radiopharmaceuticals Product Specification

Table 62. Lantheus Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Triad Isotopes Radiopharmaceuticals Product Specification

Table 64. Triad Isotopes Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. China Isotope & Radiation Radiopharmaceuticals Product Specification

Table 66. China Isotope & Radiation Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Navidea Radiopharmaceuticals Product Specification

Table 68. Navidea Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Eli Lilly Radiopharmaceuticals Product Specification

Table 70. Eli Lilly Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Dongcheng Radiopharmaceuticals Product Specification

Table 72. Dongcheng Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Advanced Accelerator Applications Radiopharmaceuticals Product Specification

Table 74. Advanced Accelerator Applications Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. SIEMENS Radiopharmaceuticals Product Specification

Table 76. SIEMENS Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Radiopharmaceuticals Production Capacity by Market Players

Table 148. Global Radiopharmaceuticals Production by Market Players (2016-2021)

Table 149. Global Radiopharmaceuticals Production Market Share by Market Players (2016-2021)

Table 150. Global Radiopharmaceuticals Revenue by Market Players (2016-2021)

Table 151. Global Radiopharmaceuticals Revenue Share by Market Players (2016-2021)

Table 152. Global Market Radiopharmaceuticals Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 155. North America Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Radiopharmaceuticals Market Share by Type (2016-2021)

Table 157. North America Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Radiopharmaceuticals Market Share by Application (2016-2021)

Table 159. East Asia Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 162. East Asia Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Radiopharmaceuticals Market Share by Type (2016-2021)

Table 164. East Asia Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Radiopharmaceuticals Market Share by Application (2016-2021)

Table 166. Europe Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 169. Europe Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Radiopharmaceuticals Market Share by Type (2016-2021)

Table 171. Europe Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Radiopharmaceuticals Market Share by Application (2016-2021)

Table 173. South Asia Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 176. South Asia Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Radiopharmaceuticals Market Share by Type (2016-2021)

Table 178. South Asia Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Radiopharmaceuticals Market Share by Application (2016-2021)

Table 180. Southeast Asia Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 183. Southeast Asia Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Radiopharmaceuticals Market Share by Type (2016-2021)

Table 185. Southeast Asia Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Radiopharmaceuticals Market Share by Application (2016-2021)

Table 187. Middle East Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 190. Middle East Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Radiopharmaceuticals Market Share by Type (2016-2021)

Table 192. Middle East Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Radiopharmaceuticals Market Share by Application (2016-2021)

Table 194. Africa Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 197. Africa Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Radiopharmaceuticals Market Share by Type (2016-2021)

Table 199. Africa Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Radiopharmaceuticals Market Share by Application (2016-2021)

Table 201. Oceania Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 204. Oceania Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Radiopharmaceuticals Market Share by Type (2016-2021)

Table 206. Oceania Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Radiopharmaceuticals Market Share by Application (2016-2021)

Table 208. South America Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 211. South America Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Radiopharmaceuticals Market Share by Type (2016-2021)

Table 213. South America Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Radiopharmaceuticals Market Share by Application (2016-2021)

Table 215. Rest of the World Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Radiopharmaceuticals Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Radiopharmaceuticals Market Share (2016-2021)

Table 218. Rest of the World Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Radiopharmaceuticals Market Share by Type (2016-2021)

Table 220. Rest of the World Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Radiopharmaceuticals Market Share by Application (2016-2021)

Table 222. North America Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 223. East Asia Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 224. Europe Radiopharmaceuticals Consumption by Region (2016-2021)

Table 225. South Asia Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 226. Southeast Asia Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 227. Middle East Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 228. Africa Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 229. Oceania Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 230. South America Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 231. Rest of the World Radiopharmaceuticals Consumption by Countries (2016-2021)

Table 232. Global Radiopharmaceuticals Production Forecast by Region (2022-2027)

Table 233. Global Radiopharmaceuticals Sales Volume Forecast by Type (2022-2027)

Table 234. Global Radiopharmaceuticals Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Radiopharmaceuticals Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Radiopharmaceuticals Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Radiopharmaceuticals Sales Price Forecast by Type (2022-2027)

Table 238. Global Radiopharmaceuticals Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Radiopharmaceuticals Consumption Value Forecast by Application (2022-2027)

Table 240. North America Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 241. East Asia Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 242. Europe Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 243. South Asia Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 245. Middle East Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 246. Africa Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 247. Oceania Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 248. South America Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Table 250. Global Radiopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)

Table 252. Global Radiopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Radiopharmaceuticals Revenue Market Share by Type (2022-2027)

Table 254. Global Radiopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Radiopharmaceuticals Revenue Market Share by Application (2016-2021)

Table 256. Global Radiopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Radiopharmaceuticals Revenue Market Share by Application (2022-2027)

Table 258. Radiopharmaceuticals Distributors List

Table 259. Radiopharmaceuticals Customers List





Figure 1. Product Figure

Figure 2. Global Radiopharmaceuticals Market Share by Type: 2021 VS 2027

Figure 3. Global Radiopharmaceuticals Market Share by Application: 2021 VS 2027

Figure 4. North America Radiopharmaceuticals Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 6. North America Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 7. United States Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 8. Canada Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 12. China Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 13. Japan Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 15. Europe Radiopharmaceuticals Consumption and Growth Rate

Figure 16. Europe Radiopharmaceuticals Consumption Market Share by Region in 2021

Figure 17. Germany Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 19. France Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 20. Italy Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 21. Russia Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 22. Spain Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 25. Poland Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Radiopharmaceuticals Consumption and Growth Rate

Figure 27. South Asia Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 28. India Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Radiopharmaceuticals Consumption and Growth Rate

Figure 30. Southeast Asia Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 31. Indonesia Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Radiopharmaceuticals Consumption and Growth Rate

Figure 37. Middle East Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 38. Turkey Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 40. Iran Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 42. Africa Radiopharmaceuticals Consumption and Growth Rate

Figure 43. Africa Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 44. Nigeria Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Radiopharmaceuticals Consumption and Growth Rate

Figure 47. Oceania Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 48. Australia Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 49. South America Radiopharmaceuticals Consumption and Growth Rate

Figure 50. South America Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 51. Brazil Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Radiopharmaceuticals Consumption and Growth Rate

Figure 54. Rest of the World Radiopharmaceuticals Consumption Market Share by Countries in 2021

Figure 55. Global Radiopharmaceuticals Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Radiopharmaceuticals Price and Trend Forecast (2022-2027)

Figure 58. North America Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 59. North America Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 75. South America Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 79. East Asia Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 80. Europe Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 81. South Asia Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 82. Southeast Asia Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 83. Middle East Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 84. Africa Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 85. Oceania Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 86. South America Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 87. Rest of the world Radiopharmaceuticals Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Radiopharmaceuticals

Figure 89. Manufacturing Process Analysis of Radiopharmaceuticals

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Radiopharmaceuticals Supply Chain Analysis